Fieldpoint Private Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$27K Sell
669
-1
-0.1% -$50 0.01% 579
2022
Q1
$44K Hold
670
0.01% 624
2021
Q4
$67K Hold
670
0.01% 520
2021
Q3
$84K Hold
670
0.02% 451
2021
Q2
$70K Sell
670
-10
-1% -$1.34K 0.02% 498
2021
Q1
$104K Sell
680
-199
-23% -$30.1K 0.02% 395
2020
Q4
$113K Buy
+879
New +$101K 0.03% 386

Other funds holding GH

Fieldpoint Private Securities's GH Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Guardant Health (GH) stake by 0.15% in Q2 2022, selling an estimated $50 and leaving 669 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #579.

Fieldpoint Private Securities first reported a position in GH in Q4 2020 and has held it in 7 quarters since. The position peaked at $113K in Q4 2020. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Fieldpoint Private Securities held 669 shares of Guardant Health worth $27K as of Q2 2022.
  • Fieldpoint Private Securities sold 1 Guardant Health share in Q2 2022, an estimated $50.
  • Guardant Health made up 0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #579 holding.
  • Fieldpoint Private Securities first reported a position in Guardant Health in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Guardant Health position peaked at $113K in Q4 2020.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.